Long term biomonitoring and risk assessment of decabromodiphenylether (DBDE) in humans

Long term biomonitoring and risk assessment of decabromodiphenylether (DBDE) in humans - Human Deca Study.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON30437

Enrollment

Registered

2007-06-05

Start date

2007-07-13

Completion date

Unknown

Last updated

2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

general safely margin for human exposure nvt

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: female 20-40 yr old

Exclusion criteria

Exclusion criteria: Occupational exposure to DBDE

Design outcomes

Primary

Measure	Time frame
Primary research variables/measurements of results Blood concentrations in humans. Expected levels will be in the part per trillion (ng/kg lipid weight) to low part per billion (µg/kg lipid weight) range. Individual variation might be one to two orders of magnitude in background situations.	—

Countries

Netherlands

Outcome results